MonoSol Rx pulls IPO

MonoSol Rx (Warren, N.J.) withdrew its IPO last week. The company said, "terms currently obtainable in the public marketplace are not sufficiently attractive to warrant proceeding with such an offering." The company filed in May 2007 to raise up to $86.3 million and then in August amended the offering to sell 4 million shares at $16-$18. A $17 price would have raised $68 million and valued the company at $255.5 million. Cowen; CIBC World Markets; and Susquehanna were the underwriters. ...